The TradingView Show: Post-Election Trades with TradeStationJoin us for our recurring series as we dive deep into the latest market movements, emerging trends, and key financial news with @TradeStation. This monthly show is designed to keep traders and investors up to date on the developments that truly move the markets. Don’t forget to explore our comprehensive video library on our profile—scroll back to catch past episodes, and follow our TradingView account to stay in the loop.
In this episode, we’ll provide actionable insights and educational resources for new traders, including charting tips and an introduction to market dynamics.
Here’s what we’ll be covering this time:
- A detailed analysis of NVIDIA’s earnings and what they mean for tech and semiconductor stocks
- How rising interest rates are influencing market sentiment and trading strategies
- Post-election trades: positioning for the rest of the year
- End-of-year trading opportunities: sectors and stocks to watch
- A look at the energy sector and how oil prices are affecting energy stocks
- Insights into the banking sector’s recent breakout and its potential impact
- Key ratio charts to help inform your strategy
- And much more!
Our live show airs monthly, welcoming traders of all experience levels to join the conversation, ask questions, and gain insights into what’s moving the markets. We encourage you to engage—leave comments, share your thoughts, and spread the word with fellow traders!
This show is sponsored by TradeStation. TradeStation pursues a singular vision to offer the ultimate online trading platform and services for self-directed traders and investors across the equities, equity index options, futures, and futures options markets. Equities, equities options, and commodity futures products and services are offered by TradeStation Securities Inc., member NYSE, FINRA, CME, and SIPC.
See below:
www.tradestation.com
www.tradestation.com
Tradestation
The TradingView Show: Charting Big Moves with TradeStationJoin us for our recurring series as we breakdown in great detail the latest market movements, emerging trends, and critical financial news with @TradeStation. This monthly show is meticulously crafted to keep traders informed about the developments that truly impact the markets. Explore our comprehensive video library on our profile—just scroll back to catch up on past episodes. And remember to follow our @TradingView account to ensure you never miss a show.
For our new traders, this episode will provide actionable insights, educational resources on charting, and a robust introduction to market dynamics.
In this episode, we’ll cover the following topics:
- Top-down analysis for informed decision-making
- Essential crude oil charts and their implications for energy stocks
- Insights into small-cap trends
- A deep dive into semiconductor stocks like ASML and NVDA
- The recent breakout in the banking sector
- An analysis of ratio charts for strategic positioning
- And much more!
Our show goes live each month, welcoming traders and investors of all levels to join the discussion, ask questions, and gain insights into what’s moving the markets. We encourage you to engage—leave comments, share your thoughts, and spread the word with your friends.
This show is sponsored by TradeStation. TradeStation pursues a singular vision to offer the ultimate online trading platform and services for self-directed traders and investors across the equities, equity index options, futures, and futures options markets. Equities, equities options, and commodity futures products and services are offered by TradeStation Securities Inc., member NYSE, FINRA, CME, and SIPC.
See below:
www.tradestation.com
www.tradestation.com
Thank you for tuning in!
The TradingView Show: Interest Rates and AI with TradeStationJoin us for our newest episode with David Russell , Head of Market Strategy at TradeStation . We’ll dive into the current market landscape, covering all of the following topics for traders:
1. Market Trends: We’ll provide detailed insights into major stocks and bullish market trends, focusing on META, NVDA, and the evolving landscape of Chinese stocks. Discover how hedge fund managers are navigating these markets and uncover other significant movements you might be missing.
2. Index Review and Interest Rates: Our analysis will dive into macro trends affecting the SPX and NDX, exploring the importance of major indexes. We’ll discuss how rising interest rates are influencing market behavior and the broader economic implications for investors.
3. Commodities: Get the latest updates on oil, especially in light of recent production cuts that are impacting prices globally. We’ll also discuss gold and silver prices, examining why gold has achieved an all-time high while silver remains undervalued and what that means for future trends.
4. Cryptocurrency: Take a closer look at Bitcoin’s recent performance. We’ll explore whether it is on the verge of forming a significant new trend and what factors are driving its volatility in today’s market.
5. Housing Market: Analyze current trends in the housing market and what lies ahead, especially as they relate to rising interest rates, advancements in AI, and productivity improvements. This segment will provide essential insights for anyone interested in real estate investments.
And much more! We encourage you to ask questions and share your feedback in the comments. Now, some important links for you to explore and read:
Explore TradeStation ideas on TradingView here: www.tradingview.com
For important disclosure information regarding options, ETFs, and more, please visit:
1. www.tradestation.com
2. www.theocc.com
3. www.tradestation.com
Thanks for watching and we'll be back live next month!
The TradingView Show: Charting Big Rotations with TradeStationOur discussion will dive into the breakout charts of small caps, the ongoing chatter about interest rates, and the shift among Fed members towards a dovish stance. We'll also examine the implications of the slowing AI stock boom and the increasing participation of stocks in catching a bid in the broader market.
The TradeStation team actively shares their daily insights and research on TradingView, providing a rich platform for interactive learning. Their repository includes powerful trading scripts designed to equip traders with effective tools for market analysis and execution.
Understanding these market dynamics is crucial, especially during seasonal shifts like those often observed in summer, where distinct patterns in market behaviors, such as those seen in the S&P 500, emerge. Charting and research play pivotal roles in navigating these fluctuations, offering insights into potential opportunities and risks. By leveraging these tools, traders can make informed decisions aligned with evolving market conditions, enhancing their ability to thrive in dynamic trading environments.
Explore all TradeStation ideas on TradingView here: www.tradingview.com
As you follow the discussion, feel free to ask questions in the comments, share your feedback, and chart alongside us by typing the respective symbol into the symbol search.
The TradingView Show takes place monthly, spotlighting TradingView community members and focusing on educational and informational content. Join us to expand your knowledge and insights into equities, AI, crypto, gold, forex, and more.
Compliance and disclaimers:
Important information: www.tradestation.com
Disclosure options: www.theocc.com
ETF prospectus page: www.tradestation.com
ARM , US Stock153 below trendline breakdown possible
21 ema below close yesterday
if sustain tl below 150/145/135 to test soon
NET Support breakdown possible , US Stock76 below Support breakdown possible
21 ema below close
73/71/68 expected to test soon
BA Channel breakdown possible , US Stock Channel breakdown possible 179 below
price close below 21 ema
176/172/168 expected to test soon
AMZN trendline breakdown possible , US Stock181 Below trendline breakdown possible
180/178/175/170/166 can test if sustain below that level
NVDA breakdown possible , US Stock119 below trendline breakdown possible 117/114/105...96 can test to fill the gap
QQQ H& S Pattern breakdown possible , US ETF474 below Trendline breakdown possible 472/470/460 can test soon
Also have H& S pattern which have target 440
The TradingView Show: Breakout Charts with TradeStationWatch our latest episode of The TradingView Show and dive deep into the markets with TradeStation and their Head of Strategy. We examine breakout charts, significant money movements, and invaluable educational insights for traders of all levels.
For daily charts and research, visit the TradeStation profile on TradingView, where they share scripts and engaging charts. They're also a connected broker allowing for instant connectivity between TradeStation and TradingView. See the official TradeStation broker profile here: www.tradingview.com
The TradingView Show occurs monthly, focusing exclusively on market education and welcoming traders of all backgrounds. Each episode dives into a variety of topics, including equities, AI, crypto, gold, forex, and more, offering a comprehensive roundup of market trends and developments that are capturing traders' attention.
Please note, the TradingView Show is dedicated solely to education, offering valuable insights and lessons for traders at every stage of their journey. It is important to emphasize that the show does not provide financial advice or recommendations; its primary goal is to enhance trader knowledge and understanding through educational content, including TradingView tips, scripts, charting techniques, and social networking.
For more, please check out the compliance and disclaimers links below:
1. Important information: www.tradestation.com
2. Disclosure options: www.theocc.com
3. ETF prospectus page: www.tradestation.com
Thanks for watching! We'll see you at our next show.
HOW TO SET *** TRAILING *** STOP LOSSES ON TRADINGVIEWThis one is a bit of a hack but follows on from my video on how to set STOP LOSSES on TradingView for Connected Brokers.
To set a TRAILLING STOP LOSS you need to open your broker account, set the trade there and it will then be reflected on the TradingView interface.
Basically a set and forget type approach.
BITCOIN VS SCIENTIFIC TRADING TOOLS Bitcoin price is likely to continue to the 24000 area and then from this zone price is like to hit the long waited 150,000usd
TMO - Bullish Price ActionTMO has broken through the 8, 13, and 21 daily exponential moving averages in the past few trading sessions. As a leader in laboratory diagnostics and life science sales distribution, it would seem reasonable that the stock may try to push higher as the coronavirus cases continue to grow. Now that the stock has pushed passed the 21 day EMA, there are no foreseeable areas of resistance for the stock and could make its way back up to recent highs nearing $530 per share. I would anticipate a slight pullback towards the 21 day EMA as stock rarely blast higher without some consolidation, but I would say that I am overall bullish on this stock until we reach previous highs.
REMEMBER: Reference to specific securities should not be construed as a recommendation to buy, sell or hold that security. Specific securities are mentioned for educational and informational purposes only. YouCanTrade is an online media publication service which provides investment educational content, ideas and demonstrations, and does not provide investment or trading advice, research or recommendations.
NIO:NYSE - SuperTrail and Trade Station working togetherLot happening in this chart of NIO, but thought I'd just show you how a live trade looks in TradingView using Trade Station.
You can see on the right hand side where I bought the stock (added automatically by TradingView and doesn't move), and where my current stop loss is set (this one I can adjust and move up and down to change my stop). I could also add a take profit (also adjustable) if I wanted to try and take advantage of spikes - like in this case where it spiked just short of $21 before pulling back.
You can see at a value of 20% for a SuperTrail / Trailing Stop Loss where I have entered and exited the trade (as confirmed by the Trade Station buy line). You can also see the approximate gains made if you had trusted and followed the trail. I think its interesting how before and after the buy and sell the 20% signal remained true for this period.
Best thing I like about the trading integration with Trading View is how easy it is to visualise where your entry and exits are, and you can literally just drag the line up and down to change your position. Its cool. I like it.
Clorox (CLX) - Catching the PivotAs mentioned before, Clorox ( NYSE:CLX ) has been one of those steadily rising stocks that appear to be benefiting from the Coronavirus. Logically, it makes sense that a company like Clorox would do well during a time where sanitation is of the utmost importance. It's not surprising to see that CLX is on the rise, however, even rising stocks need to take a breather once in a while, catch their breath, and then continue on their path. Usually, I use the 8, 13, and 21 EMAs to locate potential pullback trades, however, this particular stock seems to gravitate more accurately to the lower Keltner band before pivoting upwards. I have marked other pivot points with white arrows that confirm CLX has bounced in the past in relation to the lower keltner channel band. As always past performance does not indicate future results.
I reduced the opacity on my EMAs so you can see the Keltner channel lines more clearly, putting less strain on the eyes. Nothing like a chart full of lines to put your mind into analysis paralysis. My guess here is CLX might find support as it has done in the past at the lower Keltner channel and continue moving upward with its current trend. Therefore, I will flag this idea as bullish and see what happens.
Tesla- Waiting for a pullbackTSLA soared to all time highs this week... and though it would be fun to jump in on the action, it just feels like Iwould be entering no man's land to be bullish on TSLA at such a high price. I am going to be watching for a pull back somewhere between the 13 and 21 EMA over the next 7 to 10 days. What goes up, usually comes down. This is one that I will be waiting for in the days to come.
SPY - Is support beneath the 21 Day EMA?What a wild ride its been for the markets! I am definitely having a beer after this week is over... but before we kick off the weekend, we have to take a look at the SPY.
As you all know, I like to look for trade setups when trending stocks pull back to their 21 daily exponential moving average. Today is no exception. SPY has been trending higher over the last 3 months and with the help of the last two days, the SPY has pulled back near it's 21 day moving average.
However, I am not entirely sure that this is a pull back opportunity that I would trade just yet. There is a previous resistance level resting just below the 21 day EMA, near 295. So, SPY could keep moving lower. Also, today is Friday, so taking and holding positions in SPY (or in anything for that matter) over the weekend is a bit risky given the current environment. Consider that next week could easily gap up or down in either direction by a few hundred points.
I would like to see what happens on Monday first. Have a great weekend everybody!
Raytheon (RTX) - Pull back or breakout?Here at YouCanTrade, we have been keeping watchful eye on defensive stock Raytheon NYSE:RTX , which has been trading below its 8 day EMA over the past 2 weeks of trading. The last two days of positive market activity has helped Raytheon pullback to its 21-day moving average, which could be a signal for taking a position in the direction of the downward trend. However, the option volume tells a slightly different story. The current call volume for RTX is 14,500 calls, largely outweighing the 5000 puts traded today. That is nearly 3 times as much volume on RTX calls than puts.
So, I am going to watch this trade idea and put it to the test.
As of 12 pm ET on May 19th, the RTX 59 strike puts expiring June 19th, 2020 are trading at a mid-price of $2.50. I am simply going to monitor the price change on this put option over the next few days to see who got it right. The bulls? or the bears?
Could Real Estate be the next "Shoe" to drop?AMEX:REK Though it may be a little early to tell, we might just might see a buyer's market emerging in real estate in the next few months to come.
Although, not a popular ETF, this short ProShares ETF seeks a return that is -1x of the Dow Jones U.S. Real Estate Index. I know it's probably not most pleasing though to think the real estate market could go down, but it is possible that the recent 3 million Americans unemployed due to the Coronavirus could be one of the first signs of an economic slowdown. Historically, if you look at how monetary policy plays a role into the economy, lowering the Fed Funds rate helps loosen credit so that banks and business pay less interest. However, this in turn often affects fixed income and mortgage rates.
After the 2008 Financial crisis, the Federal reserve initiated QE, short for quantitative easing, which can be thought of as an injection of money into the heart of our financial system... or as like to say "printing money." We have seen a similar action taken by the Federal Reserve recently. Under "normal" conditions real estate prices move opposite of mortgage rates. You either spend more money for a house or commercial property and pay a lower interest rate, or you wait for real estate prices to fall, but enter a mortgage with a bit of a higher interest rate.
In this situation, we have unemployment on the rise in the U.S. and globally. Businesses around the world are closing... some of which may be permanent, people are not spending money, and may fall in debt. In some states, such as California, major banks have a 90 day waiver on residential mortgage payments to provide time for people to get back to work. However, it is uncertain if many of the unemployed population will have a job to return to in order to meet their obligations to the bank.
Throughout the bull market, shares of REK have been steadily declining as interest rates have been near 0 for most of that time, allowing the economy to strengthen. However, since the initial drop on Feb 28th, 2020, REK has increased by 50% and the average volume has since increased 10-fold. On a daily basis, the average volume of shares traded has been ~24,000 range. In recent days that number has increase to ~240,000.
What are your thoughts? Where do you see Real Estate heading in the next few months to come?
Boeing's wild ride!The aircraft manufacturer has really gone through ups and downs coming into 2020.
Contributing to the recent declines have been the ongoing issues with the 737 Max crashes in 2019 which led to the FAA suspending the aircraft from flying hurting many airlines such as Southwest, United Airlines, and American Airlines. Also adding to the pain is the Coronavirus pandemic which has suspended all non-essential travel nationwide.
Boeing traded at a low of $89 on March 18th, 2020 and today traded (March 25th) at a high of $174.77 due to optimism amid congress passing a stimulus package that would grant passenger and carrier airline $58B in loan or loan guarantees from the federal government. Buyers who took advantage of the recent lows have already made 100% returns on the stock and Boeing pays of $8.22, that’s a 9.23% yield for those who bought when BA was trading at $89/share! NYSE:BA
$CVM - CEL-SCI - Using the bodies immune system to fight cancersStill playing around with buying shares directly in Trading View via Trade Station and REALLY liking it so far. Super simple. Took a punt on CVM as it looks to have broken above a multiple resistance area, has broken above its upper bollinger band, has good volume, OBV is up, and the RSI is showing it has demand behind it and is still at fair value.
As for the company itself, I do like the idea of using the bodies own defence systems and turbo boosting them to fight cancers and other diseases. These "discovery" type stocks can however be highly volatile and can rocket or plummet on news.
You can see on the chart in the blue buy box I bought 100 @ $9.09 and they are now at $9.60 - and the green $58.48 in the box is how much I am up for the stock so far. You can also see that I have a sell stop (ie sell at market) if the stock hits $7 or below. This sell stop is easy to drag up and down, so I can have a look each day and very quickly visually check on say the 1 Day and 15 minute charts to see if I want to move it up or down. I can also very quickly flick between my moving averages views and my bollinger band views to see if I want to make it tighter or looser depending one whats happening in the market. Very cool. I like it :)
I don't have a take profit order in but that is also easily set and movable. Sometimes on these speculative type shares I might have a 15% take profit to capture any sudden rises before they pull back. For now I will monitor this one manually and move my stops as it progresses. Note that I will almost never move a stop down. They are there for a reason. Id prefer to take the $5 brokerage hit and get out and buy back in if one of my stops gets taken out.
CVM is also my mothers initials so fingers crossed this one rockets :) (<- Not a buy recommendation by any means :))
CEL-SCI Corporation is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The Company is focused on activating the immune system to fight cancer and infectious diseases. It operates through the segment of research and development of certain drugs and vaccines. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), an investigational immunotherapy under development for treatment of certain head and neck cancers, and anal warts or cervical dysplasia in human immunodeficiency virus and human papillomavirus co-infected patients and Ligand Epitope Antigen Presentation System (L.E.A.P.S.) technology, with over two investigational therapies, LEAPS-H1N1-DC, a product candidate under development for treatment of pandemic influenza in hospitalized patients, and CEL-2000 and CEL-4000, vaccine product candidates under development for treatment of rheumatoid arthritis.
